Enveric Biosciences (ENVB) Net Margin Growth (1y) (2015 - 2020)
Enveric Biosciences (ENVB) Net Margin Growth (1y) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4,168.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 673.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2,208.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 29,636.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -392.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -1,652.00 |
| 10 | Enveric Biosciences | 5.42 Mn | -2.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -1,191.00 |
| Jun 30, 2020 | -799.00 |
| Mar 31, 2020 | -131.00 |
| Dec 31, 2019 | 16,411.00 |
| Sep 30, 2019 | -3,743.00 |
| Jun 30, 2019 | -5.00 |
| Mar 31, 2019 | 85.00 |
| Dec 31, 2018 | -17,971.00 |
| Sep 30, 2018 | 7,350.00 |
| Jun 30, 2018 | 1,853.00 |
| Mar 31, 2018 | -934.00 |
| Dec 31, 2017 | -2,402.00 |
| Sep 30, 2017 | -1,911.00 |
| Jun 30, 2017 | -1,277.00 |
| Mar 31, 2017 | 575.00 |
| Dec 31, 2016 | 3,362.00 |
| Sep 30, 2016 | -1,209.00 |
| Jun 30, 2016 | -1,808.00 |
| Mar 31, 2016 | -4,077.00 |
| Jun 30, 2015 | -1.00 |